TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR
Possibilities of angina pectoris pharmacotherapy are analyzed. Achievement of target heart rate (HR) 55-60 beats per minute in these patients is possible due to three classes of antianginal medications that slow down HR: beta blockers (BB), If-channel inhibitors, nondihydropyridine calcium channel b...
Main Author: | I. M. Sokolov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/809 |
Similar Items
-
Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment
by: Indu Dhar, et al.
Published: (2022-12-01) -
Predictors of Long-Term Mortality in Patients with Stable Angina Pectoris and Coronary Slow Flow
by: Sukru Aksoy, et al.
Published: (2023-04-01) -
Effect of Opium Addiction on Aspirin Resistance in Stable Angina Pectoris
by: Afsaneh Forood, et al.
Published: (2014-01-01) -
Pharmacological treatment of stable angina pectoris: the place of trimetazidine
by: E. A. Temnikova
Published: (2022-12-01) -
NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS
by: Y. V. Gavrilov, et al.
Published: (2015-12-01)